NCT01970098View on ClinicalTrials.gov

A Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

PHASE3CompletedINTERVENTIONAL
Enrollment

374

Participants

Timeline

Start Date

October 9, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Spinocerebellar Degeneration
Interventions
DRUG

KPS-0373, High dose

28 weeks

DRUG

KPS-0373, Low dose

28 weeks

DRUG

Placebo

28 weeks

Trial Locations (1)

Unknown

Multiple Locations

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY